Olema Pharmaceuticals (OLMA) Stock News
$OLMA · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Olema Pharmaceuticals (OLMA) in the past 30 days. BORSA’s news read on OLMA is balanced at 50/100, based on 1 company event over the past 7 days. Olema Pharmaceuticals’ next earnings report is scheduled for Monday, Nov 9.
The wire on $OLMA
newest first · updated · direct subject stories onlyOlema Oncology granted options for 261,300 shares at $7.07 to ten new hires as inducement awards. The grants are a routine disclosure under Nasdaq rules and have no direct market impact.
neutral 50 · impact 10The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
Olema Pharmaceuticals (OLMA) stock: common questions
What is the latest Olema Pharmaceuticals stock news?
The highest-impact OLMA story BORSA published in the past 30 days:
· Olema Oncology grants inducement stock options to ten new employeesIs the news on OLMA bullish or bearish?
BORSA’s news read on OLMA is balanced at 50/100, based on 1 company event over the past 7 days. It measures the news only: it is separate from price action and is not investment advice.